Dr. David Kessler, who led the FDA and later ran Operation Warp Speed, said obesity rates have jumped from 13% in the 1960s ...

Improving access and affordability could be transformative for public health, given that about 88% of Americans are ...

"Slashing health care support for low-income Californians isn't just a budget decision, it is a public health crisis in the ...

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

A current weight-loss and diabetes drug has become a surprise candidate for migraine treatment, with a new pilot study ...

A novel medication out of Sweden has shown some of the same promise in melting belly fat — without making your stomach churn.

Taking to platforms including Reddit and Telegram for guidance, buyers import small quantities, often described as research ...

Eli Lilly & Co.'s experimental weight loss pill helped patients shed pounds without serious side effects in a clinical trial, ...

Opinion: Legal scholar John Shu says a ban or restriction on direct-to-consumer drug advertisements would be illogical and ...

Novo Nordisk reported mostly mild side effects from its experimental weight-loss drug CagriSema, though results upset ...

GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...